Mayne Pharma reported $24.88M in EBITDA for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Ansell ANN:AU $ 146.3M 72.4M
Cochlear COH:AU $ 258.8M 53.6M
CSL CSL:AU $ 2.66B 1.45B
Ecofibre Ltd EOF:AU -7298000 2.85M
Healius Ltd HLS:AU $ 508.2M 264.4M
Integral Diagnostics Ltd IDX:AU 32.01M 4.51M
Nanosonics Ltd NAN:AU $ 6.27M 4.64M
Next Science Ltd NXS:AU -4892320 916.73K
Polynovo Ltd PNV:AU -1851160 213.7K
Ramsay Health Care RHC:AU $ 773.1M 44.8M
ResMed RMD:AU $ 276.57M 12.93M
Sigma Healthcare Ltd SIG:AU 22.77M 790K
Sonic Healthcare SHL:AU $ 1.54B 281.03M
Telix Pharmaceuticals Ltd TLX:AU -44291000 16.81M